What is the share price of Beryl Drugs Ltd (BERLDRG) today?
The share price of BERLDRG as on 13th June 2025 is ₹20.09. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Beryl Drugs Ltd (BERLDRG) share?
The past returns of Beryl Drugs Ltd (BERLDRG) share are- Past 1 week: -1.85%
- Past 1 month: 6.63%
- Past 3 months: -19.21%
- Past 6 months: -47.79%
- Past 1 year: -44.27%
- Past 3 years: 125.76%
- Past 5 years: 249.30%
What are the peers or stocks similar to Beryl Drugs Ltd (BERLDRG)?
The peers or stocks similar to Beryl Drugs Ltd (BERLDRG) include:What is the market cap of Beryl Drugs Ltd (BERLDRG) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Beryl Drugs Ltd (BERLDRG) is ₹10.12 Cr as of 13th June 2025.What is the 52 week high and low of Beryl Drugs Ltd (BERLDRG) share?
The 52-week high of Beryl Drugs Ltd (BERLDRG) is ₹46 and the 52-week low is ₹17.35.What is the PE and PB ratio of Beryl Drugs Ltd (BERLDRG) stock?
The P/E (price-to-earnings) ratio of Beryl Drugs Ltd (BERLDRG) is 17.75. The P/B (price-to-book) ratio is 1.13.Which sector does Beryl Drugs Ltd (BERLDRG) belong to?
Beryl Drugs Ltd (BERLDRG) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Beryl Drugs Ltd (BERLDRG) shares?
You can directly buy Beryl Drugs Ltd (BERLDRG) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Beryl Drugs Ltd
BERLDRG Share Price
20.094.96% (+0.95)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
BERLDRG Performance & Key Metrics
BERLDRG Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 16.87 | 1.13 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.21 | 6.66 | 0.83% |
BERLDRG Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
BERLDRG Company Profile
Beryl Drugs is engaged in the manufacturing of allopathic pharmaceuticals preparations.
SUNPHARMA
PE Ratio
37.00
37.00
1Y Return
11.72%
11.72%
Buy Reco %
87.88
87.88
CIPLA
PE Ratio
23.03
23.03
1Y Return
2.38%
2.38%
Buy Reco %
74.19
74.19
DRREDDY
PE Ratio
20.02
20.02
1Y Return
11.76%
11.76%
Buy Reco %
56.67
56.67
TORNTPHARM
PE Ratio
57.53
57.53
1Y Return
13.13%
13.13%
Buy Reco %
72.00
72.00
MANKIND
PE Ratio
49.29
49.29
1Y Return
6.30%
6.30%
Buy Reco %
81.25
81.25
BERLDRG Forecast
BERLDRG Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
BERLDRG
BERLDRG
Income
Balance Sheet
Cash Flow
Annual Normal View
BERLDRG Income Statement
BERLDRG Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 11.39 | 15.87 | 13.20 | 13.05 | 14.73 | 14.76 | 27.16 | 27.13 | 22.55 | 22.56 | ||||||||||
Raw Materials | 6.94 | 8.83 | 6.85 | 0.94 | 0.76 | 0.90 | 1.25 | 1.48 | 19.91 | 19.91 | ||||||||||
| Power & Fuel Cost | 0.90 | 1.04 | 1.06 | 0.77 | 0.86 | 0.85 | 1.27 | 1.54 | ||||||||||||
| Employee Cost | 1.01 | 0.77 | 0.85 | 0.97 | 1.18 | 1.31 | 1.70 | 1.93 | ||||||||||||
| Selling & Administrative Expenses | 1.22 | 2.18 | 2.06 | 2.24 | 1.92 | 2.18 | 4.50 | 4.28 | ||||||||||||
| Operating & Other expenses | 1.10 | 1.33 | 1.12 | 6.99 | 7.92 | 8.94 | 16.17 | 15.13 | ||||||||||||
EBITDA | 0.22 | 1.72 | 1.26 | 1.14 | 2.09 | 0.58 | 2.27 | 2.77 | 2.64 | 2.65 | ||||||||||
| Depreciation/Amortization | 0.38 | 0.33 | 0.32 | 0.66 | 1.27 | 1.09 | 0.81 | 1.20 | 1.25 | 1.24 | ||||||||||
| PBIT | -0.16 | 1.39 | 0.94 | 0.48 | 0.82 | -0.51 | 1.46 | 1.57 | 1.39 | 1.41 | ||||||||||
| Interest & Other Items | 0.20 | 0.13 | 0.15 | 0.32 | 0.47 | 0.46 | 0.47 | 0.55 | 0.53 | 0.53 | ||||||||||
| PBT | -0.36 | 1.26 | 0.79 | 0.16 | 0.35 | -0.97 | 0.99 | 1.02 | 0.86 | 0.88 | ||||||||||
| Taxes & Other Items | 0.07 | 0.28 | 0.21 | 0.11 | 0.11 | -0.29 | 0.22 | 0.24 | 0.29 | 0.28 | ||||||||||
| Net Income | -0.43 | 0.98 | 0.58 | 0.05 | 0.24 | -0.68 | 0.77 | 0.78 | 0.57 | 0.60 | ||||||||||
| EPS | -0.84 | 1.92 | 1.14 | 0.10 | 0.47 | -1.33 | 1.50 | 1.52 | 1.14 | 1.17 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
BERLDRG Company Updates
BERLDRG Stock Peers
BERLDRG Past Performance & Peer Comparison
BERLDRG Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Beryl Drugs Ltd | 17.75 | 1.13 | — |
| Sun Pharmaceutical Industries Ltd | 37.00 | 6.03 | 0.95% |
| Cipla Ltd | 23.03 | 4.53 | 1.06% |
| Dr Reddy's Laboratories Ltd | 20.02 | 4.01 | 0.59% |
BERLDRG Stock Price Comparison
Compare BERLDRG with any stock or ETFCompare BERLDRG with any stock or ETF
BERLDRG
BERLDRG Holdings
BERLDRG Shareholdings
BERLDRG Promoter Holdings Trend
BERLDRG Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
BERLDRG Institutional Holdings Trend
BERLDRG Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
BERLDRG Shareholding Pattern
BERLDRG Shareholding Pattern
BERLDRG Shareholding History
BERLDRG Shareholding History
Foreign Institutions
smallcases containing BERLDRG stock
smallcases containing BERLDRG stock
Looks like this stock is not in any smallcase yet.
BERLDRG Events
BERLDRG Events
BERLDRG Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BERLDRG has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
BERLDRG Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BERLDRG has not given any dividends in last 5 years
BERLDRG Dividends
BERLDRG Dividends
Hmm, looks like data is unavailable here. Please come back after some timeBERLDRG Stock News & Opinions
BERLDRG Stock News & Opinions
Articles & Videos
Earnings
Beryl Drugs reports standalone net profit of Rs 0.15 crore in the March 2025 quarter
Net profit of Beryl Drugs reported to Rs 0.15 crore in the quarter ended March 2025 as against net loss of Rs 0.35 crore during the previous quarter ended March 2024. Sales rose 33.22% to Rs 3.97 crore in the quarter ended March 2025 as against Rs 2.98 crore during the previous quarter ended March 2024. For the full year,net profit declined 24.68% to Rs 0.58 crore in the year ended March 2025 as against Rs 0.77 crore during the previous year ended March 2024. Sales declined 20.88% to Rs 21.15 crore in the year ended March 2025 as against Rs 26.73 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales3.972.98 33 21.1526.73 -21 OPM %12.591.01 -12.539.99 - PBDT0.42-0.10 LP 2.122.21 -4 PBT0.10-0.42 LP 0.871.01 -14 NP0.15-0.35 LP 0.580.77 -25 Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Beryl Drugs to hold board meeting
Beryl Drugs will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Earnings
Beryl Drugs standalone net profit declines 83.87% in the December 2024 quarter
Net profit of Beryl Drugs declined 83.87% to Rs 0.05 crore in the quarter ended December 2024 as against Rs 0.31 crore during the previous quarter ended December 2023. Sales declined 30.31% to Rs 5.31 crore in the quarter ended December 2024 as against Rs 7.62 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales5.317.62 -30 OPM %10.9210.37 - PBDT0.460.68 -32 PBT0.150.37 -59 NP0.050.31 -84 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Beryl Drugs to announce Quarterly Result
Beryl Drugs will hold a meeting of the Board of Directors of the Company on 8 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Beryl Drugs standalone net profit declines 96.30% in the September 2024 quarter
Net profit of Beryl Drugs declined 96.30% to Rs 0.01 crore in the quarter ended September 2024 as against Rs 0.27 crore during the previous quarter ended September 2023. Sales declined 30.14% to Rs 5.61 crore in the quarter ended September 2024 as against Rs 8.03 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales5.618.03 -30 OPM %9.988.97 - PBDT0.440.62 -29 PBT0.110.33 -67 NP0.010.27 -96 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Beryl Drugs to discuss results
Beryl Drugs will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Beryl Drugs to hold AGM
Beryl Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Beryl Drugs to convene AGM
Beryl Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Beryl Drugs to conduct board meeting
Beryl Drugs will hold a meeting of the Board of Directors of the Company on 3 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Beryl Drugs standalone net profit declines 30.19% in the June 2024 quarter
Net profit of Beryl Drugs declined 30.19% to Rs 0.37 crore in the quarter ended June 2024 as against Rs 0.53 crore during the previous quarter ended June 2023. Sales declined 22.93% to Rs 6.25 crore in the quarter ended June 2024 as against Rs 8.11 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales6.258.11 -23 OPM %15.8413.93 - PBDT0.781.01 -23 PBT0.500.73 -32 NP0.370.53 -30 Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 15.5%, vs industry avg of 9.02%
Over the last 5 years, market share stayed at 0.01%
Over the last 5 years, net income has grown at a yearly rate of 6.1%, vs industry avg of 15.29%